Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Lotke
Paul A
PA
Callaghan
John J
JJ
Dorr
Lawrence D
LD
Engh
Gerard H
GH
Hanssen
Arlen D
AD
Healy
William L
WL
Lachiewicz
Paul F
PF
Lonner
Jess H
JH
Nelson
Charles
C
Ranawat
Chitranjan S
CS
Ritter
Merrill A
MA
Salvati
Eduardo A
EA
Sculco
Thomas P
TP
Thornhill
Thomas S
TS
D000925:Anticoagulants / Q000627:therapeutic use*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D017211:Treatment Failure; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran; D014859:Warfarin